Page last updated: 2024-08-25

picropodophyllin and Pituitary Neoplasms

picropodophyllin has been researched along with Pituitary Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, H; Jin, K; Mu, J; Pu, J; Ruan, L; Tan, S; Wang, F; Yang, G; Zhong, A1
Axelson, M; Girnita, A; Girnita, L; Hillman, J; Karström, A; Kratz, G; Larsson, O; Thoren, M; Ulfarsson, E; Vasilcanu, D; Yin, S1

Other Studies

2 other study(ies) available for picropodophyllin and Pituitary Neoplasms

ArticleYear
Metformin suppresses growth and adrenocorticotrophic hormone secretion in mouse pituitary corticotroph tumor AtT20 cells.
    Molecular and cellular endocrinology, 2018, 12-15, Volume: 478

    Topics: Adenylate Kinase; Adrenocorticotropic Hormone; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Corticotrophs; Humans; Metformin; Pituitary Neoplasms; Podophyllotoxin; Receptor, IGF Type 1; Signal Transduction

2018
Expression and growth dependency of the insulin-like growth factor I receptor in craniopharyngioma cells: a novel therapeutic approach.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Jul-01, Volume: 11, Issue:13

    Topics: Adolescent; Adult; Cell Proliferation; Child; Craniopharyngioma; Dose-Response Relationship, Drug; Humans; Immunohistochemistry; Inhibitory Concentration 50; Insulin-Like Growth Factor I; Middle Aged; Phosphorylation; Pituitary Neoplasms; Podophyllotoxin; Receptor, IGF Type 1; Tumor Cells, Cultured

2005